I've been having memory lapses in my late 40s — is this dementia starting?

Memory lapses in midlife are common and are usually not a sign of early dementia. Perimenopause, disrupted sleep, stress, and low mood all affect cognitive sharpness in ways that are real but typically reversible. If lapses are persistent, worsening, affecting your functioning, or accompanied by other changes in language, navigation, or behaviour, a GP assessment is worthwhile. Early investigation is reassuring when normal, and important when something genuinely needs attention.

Is there anything I can actually do now to lower my dementia risk?

Yes — though no single action guarantees prevention, the WHO guidelines identify a cluster of modifiable factors with genuine evidence. Managing blood pressure is the highest-yield target in midlife. Physical activity, maintaining a healthy weight, not smoking, limiting alcohol, addressing untreated hearing loss, and treating depression all appear in the evidence. These are also the interventions that benefit cardiovascular and metabolic health — they compound well. There is no dementia-specific supplement or protocol that adds to this; the basics are the protocol.

WHO updates dementia prevention guidance — midlife is the window

What just happened

The World Health Organization has a second edition of its guidelines on risk reduction of cognitive decline and dementia, and this week the Medical Republic flagged their application in midlife clinical practice — a clinical summary for Australian GPs on how the updated WHO framework maps onto the cardiovascular, metabolic, and lifestyle guidance already embedded in everyday general practice.

The WHO guidelines are not a dramatic departure from what good general practice already does. They are a consolidation and reframing: the evidence is now clear enough that dementia is not primarily a disease of later life that begins in later life. The brain changes that lead to dementia — the accumulation of amyloid plaques, tau tangles, and vascular injury — begin decades before symptoms emerge. The window to influence that trajectory is not at 75. It is now.

Fifty-seven million people were living with dementia worldwide as of 2021, according to the WHO, with nearly 10 million new diagnoses annually. Dementia is the seventh leading cause of death globally. Women experience higher mortality rates from dementia and, globally, provide approximately 70% of dementia care hours. This is not an incidental detail — the disease disproportionately affects women both as patients and as carers, and the risk factors most modifiable in midlife are the ones most worth addressing while there is still room to move them.

The both-and

What the evidence actually supports

The WHO second-edition guidelines identify over a dozen modifiable risk factors with genuine evidence behind them. The list includes hypertension, physical inactivity, obesity, smoking, depression, hearing impairment, diabetes, social isolation, excessive alcohol use, and air pollution exposure. Traumatic brain injury also features — relevant context for anyone in contact sports, or caring for someone who plays them.

The Lancet Commission on Dementia has estimated that approximately 40% of dementia cases are attributable to modifiable risk factors — a number that is remarkable for a disease often discussed as though it were entirely hereditary or simply the result of ageing. For most people, genetics sets a background level of risk; modifiable factors determine whether they reach the threshold at which symptoms emerge.

The specific intersection with midlife matters. Hypertension in the 40s and 50s is a more powerful risk factor for later-life cognitive decline than hypertension diagnosed for the first time at 70 — by that point, vascular injury may already be done. Physical inactivity in midlife shapes not just cardiovascular health but brain volume and cognitive reserve. Untreated hearing loss, which commonly begins in the 40s and 50s, has emerged as one of the largest single attributable risks in the Lancet Commission framework — likely because it reduces cognitive stimulation and social engagement over years.

The guidelines are grounded in systematic review and, where available, randomised trial evidence. The magnitude of effect is meaningful. This is not the domain of supplements, biohacking, or expensive interventions. It is blood pressure management, exercise, hearing aids when needed, not smoking, limiting alcohol, social connection, treating depression when it is present.

What they don’t do

The guidelines do not offer a protocol that guarantees dementia prevention. The evidence is about population-level risk reduction — the factors associated with lower dementia rates at a group level — not individual certainty. Someone who does everything right will still sometimes develop dementia; someone with multiple risk factors will sometimes remain cognitively intact.

This matters because the communication around dementia prevention can, if handled poorly, become another source of health anxiety — or worse, a framework for blaming patients for a disease they develop despite reasonable effort.

The guidelines also don’t fully account for perimenopause, which for many women in their 40s and 50s is the most immediately present cognitive experience. Perimenopausal cognitive symptoms — brain fog, word-finding difficulty, memory lapses — are real, well-documented, and predominantly driven by oestrogen fluctuation and sleep disruption rather than underlying dementia pathology. They are distressing precisely because they feel like what dementia would feel like. The overlap between perimenopausal cognitive change and the dementia risk-reduction window is not coincidental in timing; they share the same decade of life.

The distinction matters clinically. Perimenopausal cognitive symptoms are typically reversible and respond to sleep management, stress reduction, and, where appropriate, hormone therapy. They are not the same as the slow neurodegeneration that precedes dementia. Naming that distinction is part of good care.

My two cents

If you are in your 40s or 50s and the word “dementia” produces a particular kind of dread — I hear that. It is one of the diseases people most fear, partly because it involves losing the self before the body, and partly because it feels as though there is nothing to be done.

The WHO framework offers something genuinely useful: a list of modifiable factors, most of which are already targets for good general practice, with real evidence behind them. Not certainty. Not a guarantee. But leverage, in the decade when leverage is available.

The highest-yield single action, if the evidence is weighted honestly, is blood pressure management. If yours is elevated and untreated, that is worth addressing with your GP — not primarily because of dementia risk, but because of the full range of cardiovascular, renal, and cognitive consequences that follow from sustained hypertension. Everything else on the list compounds that foundation.

For women specifically: if you are experiencing cognitive symptoms in perimenopause and you are worried about what they mean, a GP conversation to distinguish hormonally-mediated cognitive change from other causes is worth having. They are usually the former, and that is an important thing to know.

Verdict: yes — worth knowing about. The window is open; the interventions are ordinary and effective.

Sources cited

Dementia — WHO fact sheet (second-edition risk reduction guidelines). https://www.who.int/news-room/fact-sheets/detail/dementia
“Applying new WHO dementia risk reduction guidelines in midlife” — Medical Republic, August 2026 (AHPRA-registered access). https://www.medicalrepublic.com.au/applying-new-who-dementia-risk-reduction-guidelines-in-midlife/128548